Can GLP-1 weight loss drugs protect your brain as you age?

The Medical News ·
Health & Medicine United Kingdom

A review published in Science examines how GLP-1-based weight loss medications and emerging combination therapies may influence cognitive function through direct neurological mechanisms and improved cardiometabolic health. Observational evidence suggests a lower dementia risk among people with type 2 diabetes taking GLP-1 receptor agonists, but clinical trials have failed to demonstrate…

Read original article on The Medical News →